Aim: To investigate which visual field testing strategy yields more reliable and tolerable field analysis in a normal pediatric population. Material and Methods: 68 healthy children aged 6–13 years with no ocular or systemic diseases were included in the study. One randomly selected eye of each child underwent standard achromatic visual field analysis using a Model 750 Humphrey Field Analyzer II (Carl Zeiss Meditec, Dublin, Calif., USA). We evaluated the reliability criteria (false negative, false positive and fixation loss scores) and the duration of the visual field tests performed by Fastpac (with stimulus sizes III and V, respectively) and SITA Fast with stimulus size III. Moreover, subjects underwent Goldmann perimetry testing with stimulus V. Ability to complete the perimetry tests was also scored. Perimetric analysis was stopped before the end if signs of fatigue appeared. Mean sensitivity, mean defect and pattern standard deviation were recorded for automated tests. Results: All subjects but 8 successfully completed each of four tests. The mean duration of the tests was 4.23, 5.46, 6.35 and 11.06 min for SITA Fast with stimulus size III, Fastpac with stimulus size V, Size III and Goldmann perimetry, respectively (p < 0.001). Both false-negative and false-positive test scores were found to be significantly lower for SITA Fast with stimulus size III compared to the other automated tests (p < 0.01). Children older than 8 years (n = 35) achieved significantly higher test reliability scores (p < 0.01). Conclusion: As early detection of structural and functional visual abnormalities may be of utmost importance in the pediatric population considering many potentially serious neurological and ocular problems met with, accurate and reproducible visual field testing is vital. To achieve this goal, visual field testing with SITA Fast algorithm seemed to be a promising strategy for a pediatric population in a typical clinical setting.

Keywords:
Visual field testing strategy, Children, SITA Fast
1.
Tschopp C, Safran AB, Viviani P, Reicherts M, Bullinger A, Mermoud C: Automated visual field examination in children aged 5–8 years. Part II: Normative values. Vision Res 1998;38:2211–2218.
2.
Matsuo H, Endo N, Yokoi T, Tomonaga M: Visual fields of children. Ann Ther Clin Ophthalmol 1998;25:186–193.
3.
Souza E, Berezovsky A, Morales PH, Mello PA, et al: Visual field defects in children with congenital glaucoma. J Pediatr Ophthalmol Strabismus 2000;37:266–272.
4.
Quinn GE, Miller DL, Evans JA, Tasman WE, McNamara JA, Schaffer DB: Measurement of Goldmann visual fields in older children who received cryotherapy as infants for threshold retinopathy of prematurity. Arch Ophthalmol 1996;114:425–428.
5.
Harvey EM, Dobson V, Luna B: Long-term grating acuity and visual-field development in preterm children who experienced bronchopulmonary dysplasia. Dev Med Child Neurol 1997;39:167–173.
6.
Fleishman JA, Beck RW, Linares OA, Klein JW: Deficits in visual function after resolution of optic neuritis. Ophthalmology 1987;94:1029–1035.
7.
Myers, V, Gidlewski N, Quinn G, Miller D, Dobson V: Distance and near visual acuity, contrast sensitivity, and visual fields of 10-year-old children. Arch Ophthalmol 1999;117:94–99.
8.
Quinn GE, Fea AM, Minguini N: Visual fields in 4- to 10-year-old children using Goldmann and double-arc perimeters. J Pediatr Ophthalmol Strabismus 1991;28:314–319.
9.
Safran AB, Laffi GL, Bullinger A, Viviani P, de Weisse C, Desangles D, Tschopp C, Mermoud C: Feasibility of automated visual field examination in children between 5 and 8 years of age. Br J Ophthalmol 1996;80:515–518.
10.
Bengtsson B, Heijl A, Olsson J: Evaluation of a new threshold strategy, SITA, in normal subjects. Acta Ophthalmol Scand 1998;76:165–169.
11.
Blum HL, Peters HB, Bettman JW: Vision Screening for Elementary Schools: The Orinda Study. Berkeley, University of California Press, 1959.
12.
Johnson CA: Recent developments in automated perimetry in glaucoma diagnosis and management. Curr Opin Ophthalmol 2002;13:77–84.
13.
Tschopp C, Viviani P, Reicherts M, et al: Does visual sensitivity improve between 5 and 8 years? A study of automated visual field examination. Vision Res 1999;39:1107–1119.
14.
Mutlukan E, Damato BE: Computerised perimetry with moving and steady fixation in children. Eye 1993;7:554–561.
15.
Tschopp C, Safran AB, Viviani P, et al: Automated visual field examination in children aged 5–8 years. Vision Res 1998;38:2203–2210.
16.
Lawden MC, Eke T, Degg C, Harding GF, Wild JM: Visual field defects associated with vigabatrin therapy. J Neurol Neurosurg Psychiatry 1999;67:716–722.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.